Voyager Therapeutics Cash from Investing (TTM) Analysis

Voyager Therapeutics Inc (VYGR)

7.57 +0.07 (+0.93%) USD | NASDAQ | Apr 22, 16:00

7.57 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-141.64M
September 30, 2023	-154.41M
June 30, 2023	38.62M
March 31, 2023	27.15M
December 31, 2022	-7.339M
September 30, 2022	-26.87M
June 30, 2022	-47.25M
March 31, 2022	11.28M
December 31, 2021	65.91M
September 30, 2021	49.85M
June 30, 2021	62.87M
March 31, 2021	38.63M
December 31, 2020	113.00M
September 30, 2020	160.97M
June 30, 2020	156.23M
March 31, 2020	155.18M
December 31, 2019	-90.48M

Date	Value
September 30, 2019	-88.31M
June 30, 2019	-112.11M
March 31, 2019	-168.60M
December 31, 2018	26.47M
September 30, 2018	-62.26M
June 30, 2018	-63.84M
March 31, 2018	34.07M
December 31, 2017	-3.681M
September 30, 2017	42.70M
June 30, 2017	52.08M
March 31, 2017	56.31M
December 31, 2016	47.72M
September 30, 2016	-38.14M
June 30, 2016	-55.26M
March 31, 2016	-182.55M
December 31, 2015	-194.77M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-154.41M

Minimum

Sep 2023

160.97M

Maximum

Sep 2020

11.12M

Average

27.15M

Median

Mar 2023

Cash from Investing (TTM) Benchmarks